Scarica l'app Stockscreener
0.86
4.09%
-0.0367
Dopo l'orario di chiusura:
.88
0.02
+2.33%
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Top insider buys and sells disclosed on Friday - Investing.com
Compass Therapeutics (NasdaqCM:CMPX) Stock Price - Simply Wall Street
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com - Investing.com Australia
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com - Investing.com Nigeria
Form 4 Compass Therapeutics, Inc. For: 2 October By Investing.com - Investing.com South Africa
Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares - Investing.com
Form 4 Compass Therapeutics, Inc. For: 2 October - Investing.com India
Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares By Investing.com - Investing.com Canada
Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares By Investing.com - Investing.com India
Compass Therapeutics CAO Neil Lerner Purchases 20,000 Shares in Open Market Transaction - Kalkine Media
At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares. - Stock Titan
Compass Therapeutics (CMPX) Insider Buy: Chief Accounting Officer Neil Lerner Purchases 2,500 Shares - GuruFocus
Form 4 Compass Therapeutics, Inc. For: 25 September By Investing.com - Investing.com Nigeria
Form 4 Compass Therapeutics, Inc. For: 25 September By Investing.com - Investing.com Canada
Is Compass Therapeutics, Inc. (CMPX) the Healthcare Stocks Stock Everyone's About to Talk About? - Kalkine Media
Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares - Investing.com
Form 4 Compass Therapeutics, Inc. For: 25 September - Investing.com India
Form 4 Compass Therapeutics, Inc. For: 25 September By Investing.com - Investing.com UK
Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares By Investing.com - Investing.com Canada
After buying 2,500 shares, Compass Therapeutics (CMPX) accounting chief reports a 400,000-share position - Stock Titan
How Does FDA Feedback Change the Tovecimig Path for Compass Therapeutics (NASDAQ:CMPX)? - Kalkine Media
Compass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug - tradingview.com
Why Did Compass Therapeutics Stock Plunge Today?Compass Therapeutics (NASDAQ:CMPX) - Benzinga
Form 8K Compass Therapeutics, Inc. For: 22 September By Investing.com - Investing.com India
Compass Therapeutics (Nasdaq:CMPX)Stock Analysis - simplywall.st
CCORF Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $7 - Moomoo
CytomX Therapeutics, Inc. (CTMX) Stock Price & News - Syfe
Compass (CMPX) Earnings Update: The EPS Result Is Below Expectation in the Current Update; After Earnings: Shares Finish 0.21% Higher on the DayProfit Cycle Analysis - vinanet.vn
Compass (CMPX) Session: Finishes 4.23% Lower at $2.38; Technical Setup: the Supplied Trading Band Runs From $2.26 to $2.50 in the Current UpdateDollar Neutral Pair - vinanet.vn
NEXTBio Capital Management LP's Compass Therapeutics Inc(CMPX) Holding History - GuruFocus
Compass (CMPX) Earnings Data Review: The EPS Result Is Below Expectation in the Available Record; Investor Response: Shares Close 3.46% Higher in the Latest SessionCore Business Growth - vinanet.vn
Compass Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Stifel Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
Compass Therapeutics Inc. (CMPX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
We're Not Very Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Rate - Moomoo
Compass Therapeutics (CMPX) Climbs 3.26% to $2.22, Approaches Key ResistanceCovered Call Trade - vinanet.vn
HC Wainwright Issues Pessimistic Estimate for CMPX Earnings - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Compass Therapeutics Inc. (CMPX) Stock News Today - TradingKey
Compass Therapeutics Inc. (CMPX) Stock News Today - TradingKey
A Quick Look at Today's Ratings for Compass Therapeutics(CMPX.US), With a Forecast Between $6 to $7 - Moomoo
Compass Therapeutics (NASDAQ:CMPX) Price Target Raised to $6.00 at Piper Sandler - MarketBeat
Compass Therapeutics Inc. (CMPX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
State Street (CMPX holder) reports 9.95M Compass Therapeutics shares on Schedule 13G - Stock Titan
Compass Therapeutics, Inc. Stock 12‑Month Price Target Raised to $8.67, Implies 359% Upside - TradingView
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):